Tech Times | Nintedanib, Pirfenidone cancer drugs give hope to patients battling idiopathic ... Tech Times The two experimental drugs did not cure the patients but the worsening of their lung function was slowed down. Both nintedanib and pirfenidone appear to decelerate the progress of IPF or idiopathic pulmonary fibrosis, a previously untreatable and ... InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary ... Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis ... |
